Swiss National Bank
EPIX

Swiss National Bank’s ESSA Pharma EPIX Stock Holding History

Swiss National Bank’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-57,200
Closed -$353K – 2761
2022
Q1 		$353K Buy
57,200
+4,000
+8% +$35.2K ﹤0.01% 2647
2021
Q4 		$755K Buy
53,200
+4,100
+8% +$45.7K ﹤0.01% 2567
2021
Q3 		$393K Buy
49,100
+2,000
+4% +$31.8K ﹤0.01% 2603
2021
Q2 		$1.35M Buy
+47,100
New +$1.37M ﹤0.01% 2336

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Swiss National Bank's EPIX Position: Q2 2022 in Review

Swiss National Bank sold out of ESSA Pharma (EPIX) in Q2 2022, closing a stake of 57,200 shares — an estimated $353K sold.

Swiss National Bank first reported a position in EPIX in Q2 2021 and held it in 4 quarters. The position peaked at $1.35M in Q2 2021. 59 funds tracked by Wall St. Rank hold EPIX as of Q2 2022.

  • Swiss National Bank reported no remaining ESSA Pharma position as of Q2 2022 after selling out during the quarter.
  • Swiss National Bank sold 57,200 ESSA Pharma shares in Q2 2022, an estimated $353K.
  • Swiss National Bank first reported a position in ESSA Pharma in Q2 2021 and held it in 4 quarters.
  • Swiss National Bank's ESSA Pharma position peaked at $1.35M in Q2 2021.
  • 59 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.